Samjin Pharm, Ilsung Shinyak Co-Promotion Agreement for Hypertension Treatment ‘Azel Block’
Samjin Pharmaceutical (CEO Choi Yong-joo) announced on the 7th that it had signed a co-promotion agreement on the 1st to expand the market share of Ilsung Shinyak’s (CEO Yoon Seok-geun) third-generation CCB (a calcium channel blocker ) – type of hypertension treatment ‘Azel Block’. This joint promotion will be implemented from June. Azelblock is a […]